Literature DB >> 28373888

Research Capacity at Traditional Chinese Medicine (TCM) Centers in China: A Survey of Clinical Investigators.

Shuo Feng1, Mei Han1, Lily Lai2, Si-Cheng Wang3, Jian-Ping Liu1.   

Abstract

Background. The development of an evidence-based approach to traditional Chinese medicine (TCM), which depends on the generation of good quality evidence, requires an adequate workforce. However, the research capacity of TCM investigators is not known. Study Design. This cross-sectional study was conducted to describe the research capacity of TCM clinical investigators in China. Participants. A total of 584 participants from TCM hospitals and research centers were included. They were asked about the academic and research characteristics, needs for research capacity building, and barriers to clinical research. Results. The majority (80.82%) were qualified to at least a Master's degree, whilst a smaller proportion (40.24%) held a senior professional title. We found that academic outputs were low with the majority (62.16%) authoring less than five publications in total. The most pressing needs for building research capacity identified were training in research methodology (97.43%) and identification of research questions (86.81%), whilst the highest ranking barriers to conducting research were limited motivation, funding (40.72%), and time (37.15%). Conclusion. The methodology training, along with investment in the research workforce, needs to be urgently addressed to improve investigators' research capacity and the development of an evidence-based approach of TCM.

Entities:  

Year:  2017        PMID: 28373888      PMCID: PMC5360939          DOI: 10.1155/2017/4231680

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


1. Introduction

Evidence-based medicine (EBM) has been regarded as the optimal approach to medical practice ever since Sackett et al. introduced the concept in 1996 [1]. EBM as a concept has been widely celebrated and implemented where possible in many countries including China. The World Health Organization (WHO) has advocated a similar evidence-based approach to the practice and evaluation of traditional systems of medicine such as traditional Chinese medicine (TCM) [2]. TCM is used in the treatment and prevention of many conditions in China. Covered by healthcare insurance, TCM is considered integral to China's national health system along with conventional healthcare. Historically, TCM is based on a literature of empirical use but with a growing emphasis on the adoption of evidence-based approach. High-quality research is necessary to inform clinical practice and decision-making in TCM. In developing countries, the evidence-based medical science is weak in many areas, such as surgery, manual therapy, and oncology [3-5], even as conventional medicine research, which is better funded than TCM research. Despite an unprecedented rise in the number of TCM clinical studies conducted in China in recent years, high risk of bias and serious methodological problems are prevalent amongst TCM studies and systematic reviews published in Chinese [6, 7]. The quality of TCM research is limited by inadequate training, which has an impact on the quality of research products [8, 9]. Moreover, TCM researchers may not be regularly applying the best evidence because of lack of understanding of how to access scientific literature and how to critically appraise published evidence [10-13]. Since 2009, the Chinese government has established 16 TCM clinical research centers throughout China, with the aim of supporting research projects and cultivating clinical investigators, creating better evidence, and informing policymakers, clinicians, and patients. No study to date has reported the status of TCM investigators. We conducted a cross-sectional survey to describe the characteristics of TCM investigators and to identify perceived barriers to, and facilitators for, building research capacity.

2. Materials and Methods

2.1. Questionnaire Development

The questionnaire was developed in three stages. We performed a literature review by using the search term “research capacity” and which identified 266 publications. Two persons (FS and HM) screened these publications to identify relevant studies, without limits in terms of status of researchers or specific diseases. Key questionnaire items relevant to building or describing research capacity were then extracted from these studies. We then piloted these items on 24 investigators from TCM hospitals in Beijing. We interviewed participants using the questionnaire items which included questions such as “what do you think is the most important reflection of a clinical investigator's research capacity” and “what is the most helpful way to enhance one's research capacity?” We recorded their responses as a way of seeking suitable response options for each item. Then we invited five specialists from different TCM research fields to provide further clarification. Amongst the specialists, there were two TCM clinical experts, one methodology expert, one editor of a TCM journal, and one policy maker in State Administration of Traditional Chinese Medicine. All were senior or associate directors and had worked for more than 15 years in their areas.

2.2. Questionnaire Items

The questionnaire items contained both open and closed questions organized in four domains: social demographic characteristics (5 items), academic and research characteristics (6 items), need for research capacity building (10 items), and barriers to clinical research (open question); see Appendix.

2.3. Recruitment and Questionnaire Distribution

All the participants were TCM clinical investigators attending a methodology training course organized by the National Administration of Traditional Chinese Medicine. Four rounds of training courses were held in Beijing between 2014 and 2015. Investigators from the 16 TCM clinical research centers in provinces of China were required to attend and were invited to participate in our survey. All were key staff in TCM hospitals or research centers. Prior to the first day of each training course, members of our research team explained the purpose of the study and introduced the questionnaire. A paper version was then provided to every TCM investigator who was asked to complete it within 30 minutes, with assistance by a member of the research team if required. Responses were anonymous and were collected before the training session commenced. All the assistants were Ph.D. or graduate students of the EBM Centre in Beijing University of Chinese Medicine and had been trained before the questionnaires were distributed.

2.4. Analysis

Two members of our research team (FS and HM) entered the data we collected into Epidata 3.1. Consistency was checked in this software and corrected if inconsistent. The data was imported into SPSS (SPSS Inc., Beijing University of Chinese Medicine version 22.0). Descriptive analysis was undertaken for every item. In order to reflect the rank and scale of data, we aggregated the data and used frequency statistics to describe it. To analyze implicit factors such as the number of publications (first/corresponding author, that can be summarized as less than five/more than or equal to five), we used binary logistic regression. Covariates (education, professional title, work experience, and status of being involved in project) were tested for interaction as the model was built. If interaction existed, the association between publication and implicit factors was assessed by adjusted odds ratio (OR) with 95% confidence intervals (CI). For the covariates with more than 2 categories, the last category was considered as the reference group.

3. Results

3.1. Participation Rates

Of the 1280 questionnaires from 4 surveys in 2014-2015, 584 (45.63%) usable questionnaires were returned; the others were duplicated, incomplete, or unusable.

3.2. Social Demographic Characteristics

Social demographic characteristics of the participants are described in Table 1. Gender distribution of participants was almost equal (49.50% versus 50.50%), whilst the majority (43.15%) were 30 to 39 years of age. The majority of our participants (80.80%) held a minimum of a Master's degree qualification and the maximum part of them (40.24%) held a senior role/professional title. Just over half of our respondents (53.42%) reported working in an academic role for less than ten years.
Table 1

Social demographic characteristics of TCM clinical investigators.

Social demographic characteristics n %
Age (years)
 <3015025.68%
 30–3925243.15%
 40–4913222.60%
 ≧50355.99%
 Not provided152.57%
Sex
 Male28949.50%
 Female29550.50%
Education
 Doctor's degree17329.62%
 Master's degree29951.20%
 Bachelor's degree10618.15%
 College degree61.03%
Professional title/current role
 Professor10918.66%
 Associate professor12621.58%
 Intermediate researcher16027.40%
 Assistant researcher16127.57%
 other284.79%
Work experience (years)
 <520835.62%
 5–910417.81%
 10–14579.76%
 15–19579.76%
 >2013222.60%
 Not provided264.45%

3.3. Academic and Research Characteristics

The majority of investigators had directed a grant, whilst 16.78% of respondents had not had the opportunity to lead any kind of grant (see Table 2). A minority (12.50%) of participants had directed at least one national research grant. Most investigators (88.18%) had been involved in various levels of research projects and more than a half (55.48%) were members of national level projects. Most investigators (66.27%) reported reading less than 5 papers a month. Nearly half of investigators (48.80%) were first or corresponding authors of 1 to 5 publications, whilst the maximum part of them (42.11%) were coauthors on 1 to 5 publications. More than half had studied clinical epidemiology and medical statistics (54.11% and 56.51%, resp.). Only 30.14% of participants had studied EBM.
Table 2

Academic and research characteristics of TCM clinical investigators.

Academic and research characteristics n %
Status of directing a grant
 National level7312.50%
 Provincial/ministerial level16928.94%
 Municipal level12721.75%
 Hospital/college level10718.32%
 None9816.78%
Status of being involved in project
 National level32455.48%
 Provincial/ministerial level32856.16%
 Municipal level16127.57%
 Hospital/college level8113.87%
 None6911.82%
Number of professional articles read each month
 <117930.65%
 2–520835.62%
 6–1011619.86%
 11–20457.71%
 >20366.16%
Number of publications (first/corresponding author)
 06110.45%
 1–528548.80%
 6–1010818.49%
 11–209315.92%
 >20376.34%
Number of Publications (coauthor)
 011720.08%
 1–524642.11%
 6–1010517.93%
 11–207112.10%
 >20457.78%
Methodology Study
 Clinical Epidemiology31654.11%
 Evidence-based Medicine17630.14%
 Medical Statistics33056.51%

3.4. Relationship between Publication and Implicit Factors

As interaction existed between work experience and professional title, as well as work experience and status of being involved in project, odds ratio (OR) of implicit factors in the regression model was adjusted for work experience. Strong positive correlation was found between the number of publications and number of professional articles read each month (p < 0.001). Significant and positive correlations were also demonstrated for education background (p = 0.019), professional title (p = 0.025), status of leading/being involved in project, and work experience (p = 0.012). Those who had more publications had senior education degree and professional titles, longer work experience, and higher participation in research projects and in literature reading. However, the participation in methodology training did not influence the number of publications (p = 0.193); see Table 3.
Table 3

Multivariate analysis of publications of TCM clinical investigators.

Implicit factors p valueOdds ratio% 95 CI
Education0.019
 Doctor's degree0.03216.000[1.267, 201.798]
 Master's degree0.4262.543[0.255, 25.327]
 Bachelor's degree0.4232.630[0.247, 28.047]
 College degree
Professional title/current role0.025
 Professor0.0262.480[1.114, 5.519]
 Associate professor0.0314.217[1.136, 15.645]
 Intermediate researcher0.5581.714[0.283, 10.387]
 Assistant researcher
Work experience (years)0.012
 >200.0282.809[1.120, 7.048]
 15–190.0457.911[1.046, 59.801]
 10–140.0823.697[0.846, 16.168]
 5–90.0263.439[1.163, 10.169]
 <5
Status of being involved in project0.045
 National level0.9984616953.670
 Provincial/ministerial level0.1311.385[0.908, 2.111]
 Municipal level0.99422683641.660
 Hospital/college level0.0042.473[1.321, 4.496]
 None
Number of professional articles read each month0.000
 >200.998807737421.426
 11–200.0018150008.500
 6–100.00045.000[5.621, 360.287]
 12–50.0005.167[2.353, 11.346]
 <1
Methodology study0.193
 Trained0.1931.539[0.804, 2.947]
 Not trained

3.5. Need for Research Capacity Building

The highest ranking research capacity need was knowledge of research methodology (97.43%), which was followed by how to raise research questions (86.81%), how to write or monograph publication (84.25%), and participating in or acquiring research funding (82.53%). Approximately eighty percent (80.13%) of participants had a demand for those choices. Other important needs identified were collaboration in team (75.17%), project management (62.84%), and communication of research findings (60.27%). The least important need identified was earning degrees which ranked last of all (25.68%) (see Figure 1).
Figure 1

Need of research capacity building in TCM investigators.

3.6. Barriers to Clinical Research

We used thematic analysis to analyze this open-ended question about barriers. The three most prominent problems were limited incentives and funding (40.75%), lack of time (37.15%), and lack of methodology knowledge (35.27%). Other barriers identified are related to the difficulty in avoiding bias in project execution (18.49%), difficulty in cooperating with other departments (10.96%), budget over-runs (7.19%), and being unable to free access to literature (5.82%); see Figure 2.
Figure 2

Barriers to clinical research for TCM investigators.

4. Discussion

Our findings suggest that most TCM investigators in China are below 40 years of age and have less than 10 years' experience in an academic role. Although many investigators were highly qualified academically and had received a doctorate, the vast majority of investigators were working at below a professor's grade. Although the majority of our respondents reported they had the opportunity to conduct or assist in projects, our findings show a relatively low number of academic outputs amongst our respondents. Corresponding to this is that how to write or monograph publication was identified as one of the top ranking needs for building research capacity. Poor competency in English writing is an important factor. Poorly reported studies even if methodologically sound are not accepted by quality peer-review journals. Owing to the differences in philosophy and origin between TCM and conventional medical systems, investigators experience difficulties or delays in publishing TCM research, particularly in journals with high impact factor [14, 15]. Our findings also suggest that TCM investigators are not engaged with academic outputs: the majority of our respondents accessed fewer than 5 papers per month, which may diminish confidence in writing publication. This could be partly due to limited time, because most TCM investigators who hold practitioner positions in hospitals have an extremely large clinical workload and do not have the benefit of protected time for research [16, 17]. Our findings also indicate that knowledge of research methodology and raising research questions ought to be key priorities in developing research capacity. However, we acknowledge that our respondents were all attendees of a methodological training course and the results relating to need for methodological training may have been biased based on our sampling method. In China, research methodology courses are not compulsory for undergraduate TCM students and this may result in their weaker knowledge of research methodology. This partly explains the serious methodological deficiencies amongst Chinese-language publications, recently highlighted and criticized for blind pursuit of quantity without methodological quality [18-21]. Given the importance of methodological rigor in EBM and deficiencies within Chinese-language research, TCM investigators would welcome resources to support more investment in training and the benefit of protected time for research. The highest ranking barrier to clinical research identified was limited incentives and funding. This is possibly related to a heavy clinical workload, which results in less time to prepare research grants. Poor methodological knowledge is another disadvantage in applying for funding. These factors resulted in fewer funded grants. Consistent with this, acquiring research funding was recognized as the fourth highest ranking research capacity need but it does also signal a need for an overall increase in funding for TCM research. In 2009, the Chinese government invested just 3 billion RMB (approximately $450,000) on healthcare research and development, whilst the US National Institutes of Health (NIH) spent in excess of $30 billion that year [22, 23]. This suggests an urgent need for increased investment in healthcare research by the Chinese government, particularly funds that are allocated specifically for TCM research, which would provide a significant boost in capacity and increase the opportunities available to TCM investigators. Limitations. Due to limited resources, we were unable to pilot our questionnaire prior to the study. However, we employed other developmental methods to increase the quality of our instrument (literature review and consultation with experts). Another limitation was that respondents only had 30 minutes to complete the questionnaire and this time pressure may have influenced the responses provided; however, the questionnaire was relatively short and the closed questions reduced the burden on participants. Future research could include more qualitative research through in-depth interviews as a way of exploring complex views and perspectives about research capacity.

5. Conclusion

TCM clinical investigators in China generally had low-level of research capacity. Key priorities for building research capacity include methodological training, learning to formulate good research questions, and training to write research publications. Barriers include limited funding, lack of time, and shortcomings in methodological knowledge. Only investment in a sustainable research workforce will generate rigorous evidence on TCM treatments and practice. These areas need to be urgently addressed in order to improve the methodological quality of TCM researches and to ensure that TCM becomes increasingly evidence-based for clinicians, patients, and policymakers alike.
  21 in total

1.  Capacity for clinical research on herbal medicines in Africa.

Authors:  Merlin Willcox; Nandi Siegfried; Quinton Johnson
Journal:  J Altern Complement Med       Date:  2012-06       Impact factor: 2.579

2.  [Critical appraisal of randomized clinical trials in Chinese Acupuncture and Moxibustion from 2000 to 2006].

Authors:  Ling-Ling Geng; Ren-Sheng Lin; Xia-Yun Sun; Li Wu; Ming-Ming Zhong; Bin Zhao; Jun Zheng; Jian-Ping Liu
Journal:  Zhongguo Zhen Jiu       Date:  2008-06

3.  There are challenges in conducting systematic reviews in developing countries: the Jamaican experience.

Authors:  Nadia R Bennett; Chisa Cumberbatch; Damian K Francis
Journal:  J Clin Epidemiol       Date:  2015-02-19       Impact factor: 6.437

4.  A practical approach to evidence-based dentistry: How to search for evidence to inform clinical decisions.

Authors:  Romina Brignardello-Petersen; Alonso Carrasco-Labra; H Austin Booth; Michael Glick; Gordon H Guyatt; Amir Azarpazhooh; Thomas Agoritsas
Journal:  J Am Dent Assoc       Date:  2014-12       Impact factor: 3.634

5.  The assessment of strategic plans of a developing country for solving barriers to access evidence-based information sources.

Authors:  Mehdi Kahouei; Safollah Alaei; Sohaila Sadat Ghazavi Shariat Panahi; Jamileh Mahdi Zadeh
Journal:  J Evid Based Med       Date:  2014-02

6.  Publication pressure on Chinese doctors--another view.

Authors:  Shanquan Chen; Yao Pan; Qiang Yao; Lan Yao; Zhiyong Liu; Li Xiang
Journal:  Lancet       Date:  2014-09-13       Impact factor: 79.321

7.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

8.  Training students to appraise the quality of scientific literature.

Authors:  Sebastian P Arlt; Wolfgang Heuwieser
Journal:  J Vet Med Educ       Date:  2011       Impact factor: 1.027

9.  Pass quantity, focus on quality.

Authors:  Delong Liu; Weijing Sun; Jingzhou Hou; Ruirong Yuan; Zihai Li
Journal:  J Hematol Oncol       Date:  2015-03-18       Impact factor: 17.388

10.  GAP: From Sound Design to Practical Implementation in Clinical Trials for Traditional Chinese Medicine.

Authors:  Hongcai Shang; Boli Zhang; Zhaoxiang Bian; Youping Li; Mike Clarke; Nicola Robinson
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-25       Impact factor: 2.629

View more
  3 in total

1.  Health research capacity of professional and technical personnel in a first-class tertiary hospital in northwest China: multilevel repeated measurement, 2013-2017, a pilot study.

Authors:  Peijing Yan; Yongfeng Lao; Zhenxing Lu; Xu Hui; Biao Zhou; Xinyu Zhu; Xiaojie Chen; Li Li; Zixuan Wang; Min Zhang; Kehu Yang
Journal:  Health Res Policy Syst       Date:  2020-09-17

2.  A methodological framework for tackling confounding by indication when assessing the treatment effects of Chinese herbal injections in the real world.

Authors:  Jing Tan; Chunrong Liu; Mingxi Li; Hongcai Shang; Wen Wang; Ling Li; Yiquan Xiong; Shiyao Huang; Chaolong Rao; Xiaochao Luo; Yana Qi; Jing Wang; Kang Zou; Xin Sun
Journal:  J Evid Based Med       Date:  2022-02-24

Review 3.  The science behind TCM and Gut microbiota interaction-their combinatorial approach holds promising therapeutic applications.

Authors:  Wenrui Xia; Bei Liu; Shiyun Tang; Muhammad Yasir; Imran Khan
Journal:  Front Cell Infect Microbiol       Date:  2022-09-13       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.